Acquisition · Activity not yet classified
Alliance for Multispecialty Research
Transaction overview
Reported completed
Exact closing date not established.
In a March 21, 2022 announcement, Alliance for Multispecialty Research reported a majority recapitalization by Curewell Capital in partnership with existing shareholders and management. The exact closing day, percentage and financial terms were not stated. Separate acquisitions by AMR were also described and are not treated as additional Curewell equity investments.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Curewell Capital Acquires the Alliance for Multispecialty Research (“AMR”) in Partnership with Management ↗
Official firm website · Published Mar 21, 2022
In a March 21, 2022 announcement, Alliance for Multispecialty Research reported a majority recapitalization by Curewell Capital in partnership with existing shareholders and management. The exact closing day, percentage and financial terms were not stated. Separate acquisitions by AMR were also described and are not treated as additional Curewell equity investments.